Other relevant news · Mind Medicine Australia
Mind Medicine Australia logo Menu

Other relevant news

New psychedelic trial to test whether hallucinogenic drug can help cure smoking addiction

7 News, 13 November, 2022

The US National Institutes of Health has awarded a grant to scientists at Johns Hopkins University, in the first offer of its kind in half a century.

The study, a randomised controlled trial expected to start later this year, will investigate whether psilocybin, the psychedelic compound found in “magic mushrooms”, can help people quit smoking tobacco.

Read more

The Business Trip

The Weekend Australian Magazine, 13 November, 2022

A luxe psychedelic retreat for high-flying corporate types? Will Pavia is all in

Read more

Colorado Voted to Decriminalize Psilocybin and Other Psychedelics

Time, 11 November, 2022

Colorado voters have approved the broadest psychedelic legalization in the U.S., which would decriminalize five psychedelic substances and enable adults to receive psychedelics at licensed centers. The Associated Press called the vote for the measure, Proposition 122, on Friday morning; 92% of the votes were in as of 11 a.m., with 52.3% of voters in favor.

Read more

Researchers experiment with psychedelics to treat post-traumatic stress disorder

7.30, ABC, 09 November, 2022

There are some effective therapies for people suffering from post-traumatic stress disorder, but they don’t work for everyone and with as many as one million Australians living with PTSD, the search for new treatments is gathering steam.

It’s driving a re-examination of treatments involving psychedelic drugs as James Elton reports.

Watch Video Here

With Promise of Legalization, Psychedelic Companies Joust Over Future Profits

The New York Times, 25 October, 2022

Start-ups are filing scores of patent claims on psychedelics such as psilocybin.

Read the PDF here.

Read More

The world's first Phase 3 psilocybin clinical trial is about to commence

New Atlas, 25 October, 2022

The world’s first Phase 3 human trial for day psilocybin therapy with psychological support due to commence by the end of 2022. The trial will enroll close to 1,000 participants and Compass is looking to FDA approval by the end of 2025.

Read More Here

Shroom A Magic Cure

Herald Sun, 24 October, 2022

Melbourne team makes anorexia breakthrough.

Read more

Professor Arthur Christopoulos speaks at Academy of Law and Academy of Science Joint Symposium

Academy of Law and Academy of Science Joint Symposium, 18 October, 2022

Yesterday, Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy & Pharmaceutical Sciences, and inaugural Director of the Neuromedicines Discovery Centre at Monash University, spoke at the Academy of Law and Academy of Science Joint Symposium.

He spoke of the vast divide between science and the law, in reference to the scheduling of medicines, and particularly focusing on psilocybin and MDMA. As the TGA finalises the interim decision on the rescheduling of these medicines, it would be important to keep his words in mind.

Watch Video Here

Psychedelic Medicine Is Going Beyond PTSD and Depression

Lucid News, 13 October, 2022

Though psychedelic treatments for a few major indications get all the headlines, there are many more conditions that psychedelic treatments are being investigated for.

Read more

Psychedelics are Exploding in the Startup Community as Founders Say it Makes Them Better Leaders

FortuneWell , 06 October, 2022

Ayahuasca’s effects may feel like “talk therapy on steroids” because the hallucinations reveal what many interpret as a deeper truth about themselves, their life, or life in general. Often called ayahuasca “teachings,” these visions may provide the type of self-awareness critical to being a good leader. Business leadership research shows that when leaders can regulate their own negative emotional responses, they can better identify their team’s needs and provide them the encouragement or motivation they need.

Read more

Kiwi trial to investigate psilocybin and treatment-resistant depression

NZ Herald, 28 September, 2022

A new trial is set to look into whether psilocybin could provide effective treatment for those with severe depression.

Read more

Researchers Studying Psychedelic Drug as Treatment for Alzheimer’s Disease

High Times, 21 September, 2022

A Toronto-based biotech company is studying a psychedelic drug based on DMT as a treatment for Alzheimer’s disease with a Phase ll clinical trial in Argentina.

Read more

Mushrooms for meds: Psychedelics are changing treatment ways in Israel

Y Net News, 16 September, 2022

Ecstasy for PTSD and ketamine for long-term depression – is this game changer set to revolutionize mental health treatment in Israel and elsewhere?

Read more

Is the Serotonin Hypothesis about Depression Wrong?

Amen Clinics, 30 August, 2022

For over 30 years of clinical practice, Amen Clinics has been saying that a serotonin imbalance may be present in some people with depression, but it is not the only cause of depressive symptoms. Depression is not just one thing. Find out the seven causes of depression that aren’t related to serotonin.

Read more

Psilocybin Study To Investigate the Serotonin System in Autism

Technology Networks, 07 September, 2022

Technology Networks spoke to Tobias Whelan, PhD student at King’s College London and research scientist at COMPASS Pathways, who is conducting the study, to learn more about this first-ever mechanistic study of psilocybin in autistic adults.

Read more

Psychedelic Drugs Take On Depression

Nature Briefing , 24 August, 2022

Mind-altering drugs might provide relief for those who don’t respond to conventional therapies — but does the hype outweigh the hope? What is clear is that new therapies are urgently needed. The coronavirus pandemic has left more people in mental distress than ever before. Psychedelics offer the possibility of relief for people who have no other options.

Read more

'Magic mushroom' psychedelic may help heavy drinkers quit

ABC News, 25 August, 2022

Psilocybin helped heavy drinkers cut back or quit entirely in the most rigorous test of psilocybin for alcoholism.

Read more

Psychedelic Drug Therapy a Breakthrough for Alcohol Dependence?

Medscape, 24 August, 2022

Psilocybin paired with psychotherapy is associated with a robust and sustained decrease in drinking among adults with alcohol use disorder (AUD), new research suggests.

Read the PDF here.

Read more

The long history of psychedelics in religion, from ergot-spiked wine to magic mushrooms

ABC News, 21 August, 2022

In the last century, psychedelics have gone from being at the cutting edge of medical science, to a symbol of the 1960s counterculture, and back again.

Read more

The Need For 100,000 Psychedelic Facilitators Is Real

LA Weekly, 03 August, 2022

The experts are pretty sure it’s going to take 100,000 psychedelic facilitators for the new industry to provide treatment to the masses.

Read more

Canadian patients fighting for psilocybin access sue federal government

National Post, 02 August, 2022

‘This is the landmark case that is going to legalize psychedelics in Canada’

Read more

Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up

Scientific American, 01 August, 2022

Here’s how the psychedelic substance’s legal status has been shifting.

Read more

Biden administration plans for legal psychedelic therapies within two years

The Intercept, 27 July, 2022

A letter from the Health and Human Services Department discloses the anticipated FDA approval of MDMA and psilocybin treatments.

Read more

Major health insurer opens door to psychedelic drugs

The Australian, 26 July, 2022

Health insurer says psychedelics’ medicinal potential is ‘extraordinary’ amid growing evidence MDMA and psilocybin can be used to treat some mental illnesses.

Read the full PDF here.

Read more

Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’

The Age, 23 July, 2022

Microdosing is a different way of consuming psychedelic medicines, which involves regularly taking small amounts of a psychedelic.

Read more

Biotech Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

The Australian, 21 July, 2022

In a groundbreaking development, the US FDA has just approved a clinical trial studying the effects of naturally derived psychedelic medicines.

Read the PDF here.

Read more

Brains, genes and chemical imbalances – how explanations of mental illness affect stigma

The Conversation, 20 July, 2022

For three decades, people have been deluged with information suggesting that depression is caused by a “chemical imbalance” in the brain – namely an imbalance of a brain chemical called serotonin. However, our latest research review shows that the evidence does not support it.

Read more

Psychedelics for mental health treatment

ABC Nightlife, 11 July, 2022

Writer Michael Pollan discusses how psychedelics are being used now and into the future, to successfully treat people with a range of disorders, addictions and mental illnesses.

Listen now

Can microdosing psychedelics improve your mental health? Here's what the science says

ABC News, 03 July, 2022

Early results from trials on the therapeutic potential of large doses (macrodosing) of psychedelics have been promising.

Read more

Psychedelics Give a Glimpse of Enlightenment

Psychology Today, 03 July, 2022

Our brains may be filters that are inhibiting us from experiencing reality.

Read more

Mark Turner MLA speaks at the Legislative Assembly of the Northern Territory

Mark Turner MLA: Member for Blain , 28 June, 2022

Mark Turner MLA advocates for access to psychedelic-assisted psychotherapies at the Legislative Assembly of the Northern Territory.

Read more

ACT government agrees to decriminalise small amounts of illicit drugs, such as ice, heroin and cocaine

ABC News, 09 June, 2022

The ACT is set to become the first Australian jurisdiction to decriminalise small amounts of commonly used illicit drugs, such as ice, heroin, cocaine and speed.

Read more

‘As legal as garlic’: High times in Thailand as marijuana is decriminalised

The Sydney Morning Herald, 08 June, 2022

Thailand will on Thursday become the first country in Asia to effectively legalise marijuana in a landmark move its government hopes will supercharge its wellness and tourism industries and generate as much as 10 billion baht ($400 million) per year.

Read more

How psychedelic drugs might treat depression

BBC, 07 June, 2022

Hallucinogenic mushrooms have shown promise for their medical benefits, but we are only now beginning to understand how they might help to treat depression.

Read more

New Study To Evaluate Psilocybin’s Therapeutic Potential On Autistic Adults

Neuroscience News, 04 June, 2022

A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.

Read more

Psychedelic retreats target stressed-out corporate executives

Australian Financial Review, 02 June, 2022

New businesses are focusing on jurisdictions where drugs such as psilocybin and ketamine are legal, betting they’ll be able to expand when more places decriminalise popular substances.

Read more

‘We spark curiosity’: how the psychedelics industry is taking on Davos

The Guardian, 01 June, 2022

The Psychedelic House of Davos, a satellite event happening in conjunction with the World Economic Forum, was a ‘genius strategy’ to build credibility, say experts.

Read more

A Balm for Psyches Scarred by War

The New York Times, 29 May, 2022

MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.

Read the full PDF here.

Read more

Israeli company reveals nasal spray of psychedelic mushrooms

Al-Monitor, 09 May, 2022

Madrigal Mental Care says the spray treats post-traumatic stress disorder, anxiety and other mental challenges. Some experts believe magic mushrooms have health benefits, though they come with risks.

Read more

COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression

Globe News Wire, 03 May, 2022

Positive early signals seen in two investigator-initiated studies presented at the Society of Biological Psychiatry Annual Meeting in New Orleans.

Read more

Trending Clinical Topic: Psychedelics

MedScape, 22 April, 2022

A new study examined changes in specific neurotransmitter systems and brain regions that may be responsible for various experiences associated with a psychedelic “trip”.

Read more

Australian researchers trialling magic mushroom active ingredient as antidepressant

9 News, 27 April, 2022

Sydney researchers are testing psilocybin as an alternative to antidepressants.

Read more

GoDaddy Billionaire Bob Parsons Believes Psychedelics Can Heal Trauma—And He’s Putting His Money (And Brain) On The Line

Forbes, 17 April, 2022

The Marine infantryman still suffers from PTSD from his tour in Vietnam but credits LSD and MDMA with helping him “come home.” Now he’s on a mission to help other veterans.

Read more

‘Magic mushrooms’ for PTSD therapy? Vets help sway conservatives

LA Times, 16 April, 2022

Matthew Butler spent 27 years in the Army, but it took a day in jail to convince him that his post-traumatic stress disorder was out of control.

Read more

Mushrooms’ magic compound latest hope to relieve depression

The Australian, 12 April, 2022

Early tests show lasting effects of brain ‘rewiring’ following controlled ‘trips’

Read the full PDF.

Read more

Psychedelic frees up depressed brain, study shows

BBC News, 12 April, 2022

Psilocybin appears to free up the brains of people with severe depression in a way that other antidepressants do not, a study has found.

Read more

What the science says about microdosing

Australian Financial Review, 08 April, 2022

Scientists have insight into what happens when someone takes enough psychedelics to experience hallucinogenic effects. But little research has been conducted on the effects of small doses.

Read the full PDF here.

Read more

6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in 'magic' mushrooms after authorities eased rules

Business Insider, 07 April, 2022

Six terminally ill cancer patients in Canada received the country’s first legally produced psilocybin under new rules about access to the substance.

Read more

Psychedelics may ease cancer patients’ depression, anxiety

Washington Post, 02 April, 2022

Evidence indicates that psychedelics could reduce the end-of-life anxiety that many cancer patients experience.

Read more

The Next Big Addiction Treatment

New York Times, 31 March, 2022

Psilocybin combined with therapy is emerging as one of the most effective psychedelic therapies.

Read the PDF article here.

Read more

Why microdosing is gaining momentum in Australia

Australian Financial Review, 24 March, 2022

Microdosing psychedelic drugs has been a trend in Silicon Valley that’s taking off here. But does a micro trip help you make better decisions at work?

Read the full PDF article here.

Read more

LSD, a future anti-anxiety pill?

McGill University Health Centre, 18 March, 2022

A study conducted by Gabriella Gobbi, MD, Professor and Head of the Neurobiological Psychiatry Unit in the Department of Psychiatry, and her team demonstrates for the first time that regular administration of low doses of LSD (lysergic acid diethylamide) reduces anxiety symptoms through neurobiological mechanisms that are similar to those of selective serotonin reuptake inhibitors (SSRIs).

Read more

Johns Hopkins, Yale, and NYU are teaming up to tackle a key bottleneck that will arise as psychedelics come to market

Business Insider, 11 March, 2022

As psychedelics treatments move closer to regulatory approval, there’s an issue looming in the industry: the lack of trained professionals who can handle such powerful compounds.

Read more

MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests

PsyPost, 11 March, 2022

New research provides evidence that MDMA-assisted psychotherapy can improve and extend lives of patients with chronic and severe post-traumatic stress disorder while also reducing healthcare costs.

Read more

Oklahoma House Passes Psilocybin Decriminalization Bill

Psychedelics Spotlight, 09 March, 2022

On Monday, the state’s Republican-controlled House of Representatives voted overwhelmingly, 62-30, to pass House Bill 3414, introduced by Rep. Daniel Pae (R).

Read more

4 Signs the Psychedelics Movement Is Unstoppable

Psychedelics Spotlight, 28 February, 2022

Dr. Nora Volkow, the Director of the National Institute on Drug Abuse, said earlier this year that the psychedelics “train has left the station,” and here are four big reasons to agree wholeheartedly.

Read more

Psilocybin Treatment for Major Depression Effective for up to a Year for Most Patients

Neuroscience News, 15 February, 2022

The antidepressant effect of psilocybin-assisted therapy, in combination with psychotherapy, appears to provide up to a year of symptom relief for some patients with major depressive disorder.

Read more

Two doses of psilocybin may ease depression symptoms for up to 12 months

News Medical, 15 February, 2022

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.

Read more

Plant-based Medicines

Colorado General Assembly, 10 February, 2022

Concerning establishing a policy review panel to study plant-based medicines to support mental health.

Read more

Psychedelics and the Future of Psychiatry

Psychiatric Times, 09 February, 2022

Over the past several years, we have witnessed a psychedelic renaissance, and a growing body of evidence suggests that several psychedelic compounds hold strong therapeutic potential for a wide array of mental health conditions.

Read more

Psychedelic therapy shows great promise. More states should legalise it

The Economist, 29 January, 2022

Oregon’s trailblazing sets a fine example.

Read the full PDF article here.

Read more

Sensible policy on psychedelic drugs is growing more common

The Economist, 29 January, 2022

They show tremendous potential in treating certain mental health disorders.

Read the full PDF article here.

Or listen to the topic being discussed on The Economist Podcast.

Read more

The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of

VICE, 25 January, 2022

Scientists are designing new psychedelic-inspired drugs that don’t yet exist, which might have effects no one can yet describe.

Read more

Ketamine for the treatment of alcoholism

Blossom Analysis, 24 January, 2022

Psychedelics are poised to be both viable and effective treatment options for many people living with mental disorders whom conventional treatments have failed. One of these disorders is substance use disorder (SUD), commonly known as addiction.

Read more

Psychedelics Offer New Route to Recovery from Eating Disorders

Neo.Life, 01 February, 2022

Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.

Read more

How 2021 became the year of psychedelics – and why 2022 is set to be even bigger

Canex, 20 January, 2022

It’s no secret that psychedelics are on the comeback trail, with a record number of trials and total investment in the hundreds of millions of dollars in 2021 alone.

Read more

How magic mushrooms changed my life

Financial Review (AFR), 19 January, 2022

So, can psilocybin really help those with depression? I was skeptical, but the retreat changed my mind.

Read the PDF article here.

Read more

Health Canada’s New SAP Rules: A Q&A With Numinus’ Payton Nyquvest

Psychedelic Stock Watch, 10 January, 2022

In 2020, Health Canada began tentative steps to open up legal access to psychedelics-based therapies via “exemptions” granted through its Special Access Program (SAP).

Details from the program can be found here.

Read more

$14.8 million for innovative mental health clinical trials

Health.gov.au, 07 January, 2022

Seven clinical trials testing the use of potential breakthrough combination therapies to treat debilitating mental illnesses will receive a total of almost $15 million from the Australian Government’s Medical Research Future Fund (MRFF).

Read more

Therapists hail 'legalization' of medicinal psychedelic drugs

Calgary Herald, 07 January, 2022

Local therapists say Ottawa’s move allowing physicians to prescribe psychedelics is a “seismic shift” towards legalizing their medicinal use.

Read more

Canada Opens New Legal Pathways For Access To Psychedelics Treatment With Psilocybin And MDMA

Benzinga, 05 January, 2022

In a groundbreaking decision, the Canadian government is changing the way patients can access psychedelic therapies with restricted drugs, including MDMA and psilocybin.

Read more

Depression and Grief Wrecked a Man's Life—Until He Took Magic Mushroom Ingredient

Newsweek, 26 December, 2021

Five years after taking part in a clinical trial, Kirk Rutter, spoke to Newsweek about his experiences of the trial and its impact on his mental health.

Read more

New center to study psychedelics pops up at University of Texas at Austin

My Sanantonio, 20 December, 2021

The Dell Medical School at the University of Texas at Austin is launching the Center for Psychedelic Research and Therapy, the first-of-its-kind center dedicated to the research of drugs such as psilocybin mushrooms, ayahuasca, MDMA, and ibogaine.

Read more

New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin

VICE, 16 December, 2021

The non-profit Freedom to Operate used research from chemists and crystallographers to argue in a legal filing that Compass’ form of synthetic psilocybin is not a new invention.

Read more

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×